Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Huei Yue Dai"'
Publikováno v:
Oncotarget
// Huei-Yue Dai 1 , Hui-Yu Chen 2 , Wei-Chen Lai 2 , Mien-Chie Hung 1, 2, 3, 4 , Long-Yuan Li 1, 2, 3 1 Center for Molecular Medicine, China Medical University Hospital, Taichung 404, Taiwan 2 Graduate Institute of Cancer Biology, China Medical Unive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d4d5c8dacecfbb39351bf29287f1b52
https://doi.org/10.18632/oncotarget.4278
https://doi.org/10.18632/oncotarget.4278
Autor:
Long Yuan Li, Huei-Yue Dai
Publikováno v:
Cancer Research. 79:4784-4784
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Sorafenib, a multikinase inhibitor, is the first-line target therapy for patients with advanced HCC, but the response rate is low. Thus, development of mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b227dba5ecf3d46ef36f7974a3723606
https://doi.org/10.1158/1538-7445.am2019-4784
https://doi.org/10.1158/1538-7445.am2019-4784
Autor:
San-Chi Liang, Huei-Yue Dai, Chih-Chen Hong, Ming-De Yan, Ann-Lii Cheng, Shuang-En Chuang, Gi-Ming Lai
Publikováno v:
Molecular Carcinogenesis. 47:956-963
Carbonic anhydrase III (CAIII) is distinguished from the other members of the CA family by low carbon dioxide hydratase activity, resistance to the CA inhibitor acetazolamide, and a predominant expression in the liver of males. In this report the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f663f75e868c11b433f7cfd3580fe918
https://doi.org/10.1002/mc.20448
https://doi.org/10.1002/mc.20448
Autor:
Huei-Yue Dai, 戴惠玉
96
Carbonic anhydrase III (CAIII) is distinguished from the other members of the CA family by low carbon dioxide hydratase activity, resistance to the CA inhibitor acetazolamide, and a predominant expression in the liver of males. In our animal
Carbonic anhydrase III (CAIII) is distinguished from the other members of the CA family by low carbon dioxide hydratase activity, resistance to the CA inhibitor acetazolamide, and a predominant expression in the liver of males. In our animal
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/08689843117252880115
